Assembly Biosciences (ASMB) Equity Ratio (2010 - 2026)

Assembly Biosciences' Equity Ratio history runs 17 years deep, the most recent figure standing at 0.84 for Q1 2026.

• In Q1 2026, Equity Ratio rose 207.76% year-over-year to 0.84; the TTM figure through Mar 2026 stood at 0.84 (up 207.76% YoY), while the FY2025 annual figure was 0.8, up 186.72% from the prior year.
• Equity Ratio was 0.84 for Q1 2026 at Assembly Biosciences, up from 0.8 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.9 in Q1 2022 to a low of 0.22 in Q2 2025.
• Historically, Equity Ratio has averaged 0.6 across 5 years, with a median of 0.8 in 2025.
• The sharpest annual moves came in 2024 and 2026: Equity Ratio slumped 67.9% in 2024, then jumped 207.76% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.81 in 2022, then slumped by 63.01% to 0.3 in 2023, then retreated by 6.8% to 0.28 in 2024, then soared by 186.72% to 0.8 in 2025, then rose by 5.07% to 0.84 in 2026.
• The last three Equity Ratio figures came in at 0.84 (Q1 2026), 0.8 (Q4 2025), and 0.76 (Q3 2025), per Business Quant data.